SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001516551-23-000083
Filing Date
2023-11-07
Accepted
2023-11-06 20:21:57
Documents
16
Period of Report
2023-11-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K skye-20231106.htm   iXBRL 8-K 30094
2 EX-3.1 skyebioscience-certifica.htm EX-3.1 1792
6 GRAPHIC skyebioscience-certifica001.jpg GRAPHIC 253462
7 GRAPHIC skyebioscience-certifica002.jpg GRAPHIC 203805
8 GRAPHIC skyebioscience-certifica003.jpg GRAPHIC 64455
  Complete submission text file 0001516551-23-000083.txt   873000

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20231106.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20231106_lab.xml EX-101.LAB 23083
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20231106_pre.xml EX-101.PRE 12063
10 EXTRACTED XBRL INSTANCE DOCUMENT skye-20231106_htm.xml XML 2637
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 231381257
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences